Ultra-deep sequencing of plasma DNA identifies druggable mutations in hepatocellular carcinoma. Ultra-deep sequencing of plasma DNA identifies druggable mutations in hepatocellular carcinoma

The purpose of the study is to detect somatic mutations in hepatocellular carcinoma using circulating free-DNA. We used deep-sequencing data of a panel of 60 commonly mutated genes in hepatocellular carcinoma.